Camel-IDS

Camel-IDS is a biotechnology company developing targeted radiopharmaceutical solutions for cancer. Its products are based on recombinant small antigen-binding fragments derived from Camelids' heavy-chain-only antibodies, combined with therapeutic radioisotopes.